## Cryptococcus neoformans Capsule Composition ### Structure and Composition **Glucuronoxylomannan (GXM)** is the major polysaccharide constituent of the *Cryptococcus neoformans* capsule, accounting for approximately 90% of the capsular material. This is a branched polymer composed of mannose, xylose, and glucuronic acid residues. ### Clinical Significance - **Key Point:** GXM is the primary virulence factor of *C. neoformans*, enabling immune evasion by mimicking host glycoproteins and suppressing inflammatory responses. - **High-Yield:** The capsule can be visualized using India ink staining in cerebrospinal fluid (CSF) during cryptococcal meningitis diagnosis. - **Clinical Pearl:** Serum and CSF cryptococcal antigen (CrAg) tests detect GXM and are the gold standard for diagnosis of cryptococcosis. ### Other Capsular Components While GXM is predominant, the capsule also contains: - Mannoproteins (cell wall-associated) - Minor amounts of other polysaccharides - Melanin (produced by the organism, enhances virulence) ### Distinction from Other Fungal Capsules | Organism | Primary Capsular Polysaccharide | | --- | --- | | *Cryptococcus neoformans* | Glucuronoxylomannan (GXM) | | *Histoplasma capsulatum* | Galactomannan | | *Aspergillus fumigatus* | Galactomannan | | *Candida albicans* | Mannan and β-glucan | **Key Point:** GXM's immunosuppressive properties make it a key target for vaccine development and immune-based therapies in cryptococcal disease.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.